Article
Targeting PERK and GRP78 in colorectal cancer: Genetic insights and novel therapeutic approaches.
European journal of pharmacology - 5 Nov 2024
Mafi Sahar, Dehghani Mehdi, Khalvati Bahman, Abidi Hassan, Ghorbani Marziyeh, Jalali Pooya, Whichelo Rachel, Salehi Zahra, Markowska Aleksandra, Reyes Amanda, Pecic Stevan, Łos Marek J, Ghavami Saeid, Nikseresht Mohsen
Abstract excerpt
Colorectal cancer (CRC) ranks among the leading causes of cancer-related deaths worldwide. Enhancing CRC diagnosis and prognosis requires the development of improved biomarkers and therapeutic targets. Emerging evidence suggests that the unfolded protein response (UPR) plays a pivotal role in CRC progression, presenting new opportunities for diagnosis, treatment, and prevention. This study hypothesizes that...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
